|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
3
|
Cho KH, Baek S and Sung MH: Wnt pathway
mutations selected by optimal beta-catenin signaling for
tumorigenesis. FEBS Lett. 580:3665–3670. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoang B, Moos M Jr, Vukicevic S and Luyten
FP: Primary structure and tissue distribution of FRZB, a novel
protein related to Drosophila frizzled, suggest a role in skeletal
morphogenesis. J Biol Chem. 271:26131–26137. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Banyai L and Patthy L: The NTR module:
domains of netrins, secreted frizzled related proteins and type I
procollagen C-proteinase enhancer protein are homologous with
tissue inhibitors of metalloproteases. Protein Sci. 8:1636–1642.
1999. View Article : Google Scholar
|
|
7
|
Killock D: Osteoarthritis: Frzb knockout
reveals the complexity of Wnt signaling in joint homeostasis. Nat
Rev Rheumatol. 8:1232012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lories RJ, Peeters J, Bakker A, et al:
Articular cartilage and biomechanical properties of the long bones
in Frzb-knockout mice. Arthritis Rheum. 56:4095–4103. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kristensen IB, Haaber J, Lyng MB, et al:
Myeloma plasma cell expression of osteoblast regulatory genes:
overexpression of SFRP3 correlates with clinical bone involvement
at diagnosis. Leuk Lymphoma. 54:425–427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mandal D, Srivastava A, Mahlum E, et al:
Severe suppression of Frzb/sFRP3 transcription in osteogenic
sarcoma. Gene. 386:131–138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu Y, Li JF, Cai Q, et al: Over-expression
of FRZB in gastric cancer cell suppresses proliferation and induces
differentiation. J Cancer Res Clin Oncol. 134:353–364. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zi X, Guo Y, Simoneau AR, et al:
Expression of Frzb/secreted Frizzled-related protein 3, a secreted
Wnt antagonist, in human androgen-independent prostate cancer PC-3
cells suppresses tumor growth and cellular invasiveness. Cancer
Res. 65:9762–9770. 2005. View Article : Google Scholar
|
|
13
|
Ekström EJ, Sherwood V and Andersson T:
Methylation and loss of Secreted Frizzled-Related Protein 3
enhances melanoma cell migration and invasion. PLoS One.
6:e186742011.PubMed/NCBI
|
|
14
|
Guo Y, Xie J, Rubin E, et al: Frzb, a
secreted Wnt antagonist, decreases growth and invasiveness of
fibrosarcoma cells associated with inhibition of Met signaling.
Cancer Res. 68:3350–3360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sinicrope FA, Ruan SB, Cleary KR, Stephens
LC, Lee JJ and Levin B: bcl-2 and p53 oncoprotein expression during
colorectal tumorigenesis. Cancer Res. 55:237–241. 1995.PubMed/NCBI
|
|
16
|
Geiger TR, Song JY, Rosado A and Peeper
DS: Functional characterization of human cancer-derived TRKB
mutations. PLoS One. 6:e168712011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao X, Huang H, Chen Y, et al: Dynamic
expression of secreted Frizzled-related protein 3 (sFRP3) in the
developing mouse spinal cord and dorsal root ganglia. Neuroscience.
248C:594–601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kristensen IB, Christensen JH, Lyng MB, et
al: Expression of osteoblast and osteoclast regulatory genes in the
bone marrow microenvironment in multiple myeloma: only upregulation
of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone
disease. Leuk Lymphoma. Aug 5–2013.(Epub ahead of print).
|
|
21
|
Kongkham PN, Northcott PA, Croul SE, Smith
CA, Taylor MD and Rutka JT: The SFRP family of WNT inhibitors
function as novel tumor suppressor genes epigenetically silenced in
medulloblastoma. Oncogene. 29:3017–3024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nikuseva-Martic T, Serman L, Zeljko M, et
al: Expression of secreted frizzled-related protein 1 and 3, T-cell
factor 1 and lymphoid enhancer factor 1 in clear cell renal cell
carcinoma. Pathol Oncol Res. 19:545–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hirata H, Hinoda Y, Ueno K, Majid S, Saini
S and Dahiya R: Role of secreted frizzled-related protein 3 in
human renal cell carcinoma. Cancer Res. 70:1896–1905. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin DC, Zhang Y, Pan QJ, et al: PLK1 is
transcriptionally activated by NF-κB during cell detachment and
enhances anoikis resistance through inhibiting beta-catenin
degradation in esophageal squamous cell carcinoma. Clin Cancer Res.
17:4285–4295. 2011.PubMed/NCBI
|
|
25
|
Fischer AN, Fuchs E, Mikula M, Huber H,
Beug H and Mikulits W: PDGF essentially links TGF-beta signaling to
nuclear beta-catenin accumulation in hepatocellular carcinoma
progression. Oncogene. 26:3395–3405. 2007. View Article : Google Scholar : PubMed/NCBI
|
